Nalaganje...
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
Patients with hepatocellular carcinoma (HCC) face a common type of cancer, which is amongst the most deadly types of cancer worldwide. The therapeutic options range from curative resection or ablation to loco regional therapies in palliative setting and last but not least, systemic treatment. The la...
Shranjeno v:
| izdano v: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821931/ https://ncbi.nlm.nih.gov/pubmed/33374927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14010003 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|